ESC 365 - 15 years of TAVI: increasing evidence for routine use

ESC Premium Access

15 years of TAVI: increasing evidence for routine use

Event: ESC CONGRESS 2019

Topic: Valvular Heart Disease

Session type: Advances in Science

Date: 2 September 2019

Time: 14:30 - 15:40

Congress Session

4 presentations in this session

State of the Art - Current evidence and future perspectives of TAVI

Speaker: Professor H. Baumgartner (Muenster, DE)

From first in man transcatheter aortic valve implantation, a 15-year experience.

Speaker: Doctor G. Avinee (Rouen, FR)

Clinical impact of mitral regurgitation before or following transcatheter aortic valve replacement in patients with aortic stenosis: a nationwide multivariable analysis

Speaker: Professor L. Fauchier (Tours, FR)

Early changes in quality of life after transcatheter aortic valve replacement: One-year results from the 3M TAVR Study

Speaker: Doctor S. Lauck (Vancouver, CA)

4 speakers from this session

Professor Helmut Baumgartner

University Hospital Munster - UKM, Muenster (Germany)

21 presentations

0 follower

Doctor Guillaume Avinee

Rouen University Hospital, FHU Remod-VHF, Rouen (France)

0 follower

Professor Laurent Fauchier

Tours Regional University Hospital, Hospital Trousseau, Tours (France)

12 presentations

1 follower

Doctor Sandra Lauck

St Paul's Hospital, Vancouver (Canada)

1 presentation

0 follower

This platform is supported by